Apollomics (APLM) Competitors $6.50 -0.06 (-0.84%) Closing price 07/3/2025 02:27 PM EasternExtended Trading$6.50 0.00 (0.00%) As of 07/3/2025 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock APLM vs. ENLV, INKT, COEP, SXTC, SCYX, NRSN, TPST, CARA, TENX, and LSTAShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include Enlivex Therapeutics (ENLV), MiNK Therapeutics (INKT), Coeptis Therapeutics (COEP), China SXT Pharmaceuticals (SXTC), SCYNEXIS (SCYX), NeuroSense Therapeutics (NRSN), Tempest Therapeutics (TPST), Cara Therapeutics (CARA), Tenax Therapeutics (TENX), and Lisata Therapeutics (LSTA). These companies are all part of the "pharmaceutical products" industry. Apollomics vs. Its Competitors Enlivex Therapeutics MiNK Therapeutics Coeptis Therapeutics China SXT Pharmaceuticals SCYNEXIS NeuroSense Therapeutics Tempest Therapeutics Cara Therapeutics Tenax Therapeutics Lisata Therapeutics Apollomics (NASDAQ:APLM) and Enlivex Therapeutics (NASDAQ:ENLV) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment. Which has stronger valuation & earnings, APLM or ENLV? Enlivex Therapeutics has lower revenue, but higher earnings than Apollomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomics$1.49M4.80-$53.86MN/AN/AEnlivex TherapeuticsN/AN/A-$15.01M-$0.66-1.78 Is APLM or ENLV more profitable? Apollomics' return on equity of 0.00% beat Enlivex Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A Enlivex Therapeutics N/A -57.67%-50.52% Do institutionals & insiders believe in APLM or ENLV? 19.1% of Apollomics shares are held by institutional investors. Comparatively, 1.0% of Enlivex Therapeutics shares are held by institutional investors. 12.3% of Enlivex Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts recommend APLM or ENLV? Enlivex Therapeutics has a consensus price target of $10.00, indicating a potential upside of 751.06%. Given Enlivex Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Enlivex Therapeutics is more favorable than Apollomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apollomics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Enlivex Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk and volatility, APLM or ENLV? Apollomics has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Enlivex Therapeutics has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Does the media prefer APLM or ENLV? In the previous week, Apollomics' average media sentiment score of 0.00 equaled Enlivex Therapeutics'average media sentiment score. Company Overall Sentiment Apollomics Neutral Enlivex Therapeutics Neutral SummaryEnlivex Therapeutics beats Apollomics on 6 of the 11 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLM vs. The Competition Export to ExcelMetricApollomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.77M$2.89B$5.53B$9.04BDividend YieldN/A2.44%5.24%4.02%P/E RatioN/A21.7127.6320.25Price / Sales4.80281.07417.36118.60Price / CashN/A42.7336.8958.07Price / Book1.457.518.035.67Net Income-$53.86M-$55.14M$3.18B$249.21M7 Day Performance-0.08%4.61%2.91%3.28%1 Month Performance-0.99%4.72%3.72%5.55%1 Year Performance-65.98%5.92%35.14%21.08% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMApollomics0.3472 of 5 stars$6.51-0.8%N/A-65.8%$6.77M$1.49M0.0045Gap DownENLVEnlivex Therapeutics3.1875 of 5 stars$1.12-6.7%$10.00+792.9%-11.7%$28.38MN/A-1.7070Positive NewsINKTMiNK Therapeutics3.2844 of 5 stars$7.34+5.2%$37.50+410.9%-23.8%$27.82MN/A-2.9130COEPCoeptis Therapeutics0.1962 of 5 stars$7.80+0.3%N/A+37.9%$27.34MN/A-1.342Gap UpSXTCChina SXT Pharmaceuticals0.1422 of 5 stars$1.73+0.6%N/A-78.3%$27.22M$1.82M0.0090News CoverageSCYXSCYNEXIS0.2672 of 5 stars$0.67-2.4%N/A-62.3%$26.98M$3.75M-1.2060NRSNNeuroSense Therapeutics1.723 of 5 stars$1.89-0.5%$14.00+640.7%+44.7%$25.97MN/A-3.5010TPSTTempest Therapeutics1.796 of 5 stars$6.80-1.4%$30.00+341.2%-74.0%$25.41MN/A-0.3820News CoverageCARACara Therapeutics0.3513 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580News CoverageGap DownHigh Trading VolumeTENXTenax Therapeutics1.2977 of 5 stars$5.76-1.5%$17.50+203.8%+87.4%$24.27MN/A-2.329LSTALisata Therapeutics2.519 of 5 stars$2.90+3.6%$15.00+417.2%-23.0%$24.12M$1M-1.2630Gap Down Related Companies and Tools Related Companies Enlivex Therapeutics Competitors MiNK Therapeutics Competitors Coeptis Therapeutics Competitors China SXT Pharmaceuticals Competitors SCYNEXIS Competitors NeuroSense Therapeutics Competitors Tempest Therapeutics Competitors Cara Therapeutics Competitors Tenax Therapeutics Competitors Lisata Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLM) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLM Stock Alerts